Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Using neurohormones to control keratin can lead to new skin disease treatments.

SLN suspensions work as well as commercial solutions for minoxidil delivery, but are non-corrosive, making them a promising alternative.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Light microscopy is useful for diagnosing different hair disorders.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Nanotechnology improves minoxidil treatment for hair loss.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Dermabrasion improves skin appearance by removing the top layer to promote healing.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Newer skin resurfacing lasers reduce damage and scarring, with some approved for safe use and minimal side effects.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Hair shaft dysplasias are abnormal hair conditions that can be inherited or acquired and may signal other health issues, with limited treatment options available.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Lupus can cause hair loss and nail changes, with treatments available for both.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.